BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Genaera Corp.

About Genaera:

Genaera Corporation (NASDAQ: GENR) is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Our research and development efforts are focused on anti-angiogenesis and respiratory diseases.

 

Anti-Angiogenesis Drugs

Age-related macular degeneration (AMD)

Respiratory Diseases





More on Genaera
:

Home Page

Key Statistics for Genaera

Basic Chart for Genaera

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com